Your browser doesn't support javascript.
loading
Reversible hypogonadotropic hypogonadism in men with the fertile eunuch/Pasqualini syndrome: A single-center natural history study.
Dwyer, Andrew A; Stamou, Maria; McDonald, Isabella R; Anghel, Ella; Cox, Kimberly H; Salnikov, Kathryn B; Plummer, Lacey; Seminara, Stephanie B; Balasubramanian, Ravikumar.
Afiliação
  • Dwyer AA; Boston College William F. Connell School of Nursing, Chestnut Hill, MA, United States.
  • Stamou M; Massachusetts General Hospital - Harvard Center for Reproductive Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • McDonald IR; Massachusetts General Hospital - Harvard Center for Reproductive Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Anghel E; Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States.
  • Cox KH; Boston College William F. Connell School of Nursing, Chestnut Hill, MA, United States.
  • Salnikov KB; Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States.
  • Plummer L; Boston College Lynch School of Education and Human Development, Department of Measurement, Evaluation, Statistics and Assessment, Chestnut Hill, MA, United States.
  • Seminara SB; Massachusetts General Hospital - Harvard Center for Reproductive Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Balasubramanian R; Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States.
Front Endocrinol (Lausanne) ; 13: 1054447, 2022.
Article em En | MEDLINE | ID: mdl-36407308
ABSTRACT
Congenital hypogonadotropic hypogonadism (HH) is a heterogeneous genetic disorder characterized by disrupted puberty and infertility. In most cases, HH is abiding yet 10-15% undergo reversal. Men with HH and absent and partial puberty (i.e., testicular volume <4mL and >4mL respectively) have been well-studied, but the rare fertile eunuch (FE) variant remains poorly characterized. This natural history study of 240 men with HH delineates the clinical presentation, neuroendocrine profile, rate of reversal and genetics of the FE variant. We compared three HH groups FE (n=38), absent puberty (n=139), and partial puberty (n=63). The FE group had no history of micropenis and 2/38 (5%) had cryptorchidism (p<0.0001 vs. other groups). The FE group exhibited higher rates of detectable gonadotropins, higher mean LH/FSH levels, and higher serum inhibin B levels (all p<0.0001). Neuroendocrine profiling showed pulsatile LH secretion in 30/38 (79%) of FE men (p<0.0001) and 16/36 (44%) FE men underwent spontaneous reversal of HH (p<0.001). The FE group was enriched for protein-truncating variants (PTVs) in GNRHR and FGFR1 and 4/30 (13%) exhibited oligogenic PTVs. Findings suggest men with the FE variant exhibit the mildest neuroendocrine defects of HH men and the FE sub-type represents the first identified phenotypic predictor for reversible HH.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eunuquismo / Hipogonadismo Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eunuquismo / Hipogonadismo Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article